| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.854 | 47.859 | 47.960 | 61.322 | 62.879 | 54.695 | 132.601 | 125.501 | 106.571 | 98.055 |
| Total Income - EUR | 32.858 | 47.890 | 47.988 | 61.322 | 62.895 | 54.695 | 132.765 | 125.501 | 106.573 | 98.055 |
| Total Expenses - EUR | 20.021 | 18.569 | 26.684 | 31.074 | 35.565 | 25.897 | 70.270 | 83.400 | 87.034 | 80.111 |
| Gross Profit/Loss - EUR | 12.836 | 29.321 | 21.303 | 30.248 | 27.330 | 28.798 | 62.495 | 42.101 | 19.538 | 17.944 |
| Net Profit/Loss - EUR | 11.851 | 27.885 | 19.865 | 28.409 | 25.443 | 27.349 | 58.597 | 39.839 | 18.633 | 11.955 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Stomestet Study Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.276 | 4.773 | 2.573 | 9.311 | 8.761 | 7.214 | 76.378 | 55.927 | 35.186 | 17.401 |
| Current Assets | 23.931 | 24.536 | 17.721 | 23.599 | 23.285 | 28.924 | 28.368 | 35.955 | 62.530 | 67.728 |
| Inventories | 0 | 0 | 0 | 1.596 | 977 | 1.384 | 883 | 780 | 1.451 | 889 |
| Receivables | 924 | 915 | 899 | 902 | 1.089 | 45 | 10.904 | 4.826 | 5.357 | 21.237 |
| Cash | 23.007 | 23.622 | 16.822 | 21.101 | 21.220 | 27.495 | 16.581 | 30.350 | 55.722 | 45.602 |
| Shareholders Funds | 30.154 | 27.938 | 19.917 | 28.460 | 25.493 | 31.686 | 58.645 | 68.249 | 86.675 | 37.835 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.053 | 1.371 | 376 | 4.450 | 6.553 | 4.452 | 46.101 | 23.633 | 11.041 | 47.294 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8230 - 8230" | |||||||||
| CAEN Financial Year |
8230
|
|||||||||
Comments - Stomestet Study Srl